For Providers

Introducing Allergy Drops is an Easy Process

"Patients tolerate it [allergy drops] very well and they really appreciate it once they get it going because it almost allows them to get their life back."

Provider review

Watch the review

Reviewed by

— Amy Fitzgerald, FNP, Family Practice | MN

In their own words

“As far as introducing Allergychoices, I don’t think that you should be fearful. I think that it’s a very easy process. When I have questions, Allergychoices especially is very helpful on answering questions on prescribing, where to start. The pharmacists are excellent in helping with that.

“I haven’t had any issues or major reactions. Patients tolerate it very well and they really appreciate it once they get it going because it almost allows them to get their life back. That’s the fun part, when patients can start to feel better and get back to work and school. That’s what we do, and that’s why we’re here as doctors and providers.”

Keep watching

More provider reviews

Next step

Tired of seeing your allergy patients suffer?

Call us at (866) 793-1680 or fill out this form to discuss offering this safe and effective option!

Regulatory status of allergy drops

A small number of sublingual immunotherapy (SLIT) tablets are FDA-approved for specific allergens. Personalized allergy drops are compounded by a pharmacy for each patient and prescribed off-label — a long-standing, legitimate practice with decades of use, and SLIT is a first-line prescription approach in much of Europe. Compounded allergy drops are not FDA-approved, but they are created using FDA-approved allergenic extracts, the same as in allergy shots. Off-label does not mean unsafe or experimental.

U.S. allergenic extracts are licensed and labeled for injection and skin testing, not for the sublingual route, so prescribing them as sublingual drops is an off-label clinical decision made by the treating provider.